LUTINUS

This brand name is authorized in Finland, Hong Kong, Ireland, Japan, Netherlands, Poland, Romania, Turkey

Active ingredients

The drug LUTINUS contains one active pharmaceutical ingredient (API):

1 Progesterone UNII 4G7DS2Q64Y - PROGESTERONE

Progesterone is a natural progestogen, the main hormone of the corpus luteum and the placenta. It acts on the endometrium by converting the proliferating phase to the secretory phase. Read about Progesterone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03DA04	Progesterone	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03D Progestogens → G03DA Pregnen (4) derivatives
Discover more medicines within G03DA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 081669
Country: HK	Department of Health Drug Office	Identifier(s): 64210
Country: IE	Health Products Regulatory Authority	Identifier(s): 21705
Country: JP	医薬品医療機器総合機構	Identifier(s): 2477700H2027
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 95745
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100223961, 100362154
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W55711001, W55711002
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8697621100435